PAHC Phibro Animal Health Corp

  1. Stocks
  2. Healthcare
  3. NASDAQ: PAHC

Price (delayed)

$36.35

Market cap

$1.48B

P/E Ratio

14.78

Dividend/share

$0.48

EPS

$2.46

Enterprise value

$2.15B

?
Relative Growth: Rel. Growth: 97
Relative Strength: Rel. Strength: 34
Relative Valuation: Rel. Valuation: 91
Relative Profitability: Rel. Profitability: 77

Phibro Animal Health Corporation is a leading global diversified animal health and mineral nutrition company. We strive to be a trusted partner with livestock producers, farmers, veterinarians, and consumers who ...

Highlights
PAHC's EPS has surged by 107% year-on-year and by 5% since the previous quarter
PAHC's net income has surged by 107% year-on-year and by 4.7% since the previous quarter
The quick ratio has decreased by 4.7% from the previous quarter and by 2.9% YoY
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Website: http://www.pahc.com
Peers: ICCC MRK ZTS LLY

Key stats

What are the main financial stats of PAHC

PAHC stock price

How has the Phibro Animal Health stock price performed over time
Intraday
0.72%
1 week
3.33%
1 month
3.15%
1 year
12.89%
YTD
-2.7%
QTD
15.76%

Financial performance

How have Phibro Animal Health's revenue and profit performed over time
Revenue
$1.52B
Gross profit
$512.52M
Operating income
$194.4M
Net income
$99.72M
Gross margin
33.8%
Net margin
6.6%
PAHC's net income has surged by 107% year-on-year and by 4.7% since the previous quarter
PAHC's net margin has soared by 78% YoY and by 4.8% QoQ
PAHC's operating income has surged by 76% year-on-year and by 8% since the previous quarter
The operating margin has surged by 51% year-on-year and by 7% since the previous quarter

Price vs fundamentals

How does PAHC's price correlate with its fundamentals

Growth

What is Phibro Animal Health's growth rate over time

Valuation

What is Phibro Animal Health stock price valuation
PAHC P/E details
P/E
14.78
P/B
3.83
P/S
0.97
EV/EBIT
11.81
EV/EBITDA
9.2
EV/Sales
1.41
PAHC's EPS has surged by 107% year-on-year and by 5% since the previous quarter
PAHC's P/E is 59% below its 5-year quarterly average of 36.2 and 23% below its last 4 quarters average of 19.3
The equity is up by 35% year-on-year and by 7% since the previous quarter
PAHC's P/B is 24% above its 5-year quarterly average of 3.1 but 20% below its last 4 quarters average of 4.8
The stock's price to sales (P/S) is 21% more than its 5-year quarterly average of 0.8 but 12% less than its last 4 quarters average of 1.1
The revenue has increased by 17% year-on-year

Efficiency

How efficient is Phibro Animal Health business performance
Phibro Animal Health's ROA has soared by 79% YoY and by 2.9% from the previous quarter
The return on equity has surged by 57% year-on-year but it has declined by 2.7% since the previous quarter
The ROIC has soared by 54% YoY and by 4% from the previous quarter
PAHC's return on sales has surged by 52% year-on-year and by 5% since the previous quarter

Dividends

What is PAHC's dividend history
Dividend details
DPS
$0.48
Dividend yield
1.32%
Payout ratio
19.5%
Recent dividends

Special dividends are included in TTM DPS and yield

Financial health

How did Phibro Animal Health financials performed over time
Phibro Animal Health's total assets is 35% higher than its total liabilities
Phibro Animal Health's total assets has increased by 10% YoY and by 3.9% QoQ
Phibro Animal Health's current ratio has increased by 7% YoY but it has decreased by 7% QoQ
PAHC's debt is 90% higher than its equity
The equity is up by 35% year-on-year and by 7% since the previous quarter
PAHC's debt to equity is down by 25% YoY and by 6% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.